What is Agios Pharmaceuticals's total?

Agios Pharmaceuticals (AGIO) reported total of $932.21M in Q1 2026.

How has Agios Pharmaceuticals's total changed year-over-year?

Agios Pharmaceuticals's total decreased by 30.7% year-over-year, from $1.35B to $932.21M.

What is the long-term trend for Agios Pharmaceuticals's total?

Over 5 years (2020 to 2025), Agios Pharmaceuticals's total has grown at a 14.6% compound annual growth rate (CAGR), from $543M to $1.07B.

Agios Pharmaceuticals AGIO Total

Total at other companies

BioMarin PharmaceuticalsBMRN

——

PrecigenPGEN

——

BridgeBio PharmaBBIO

——

Ligand PharmaceuticalsLGND

——

AmgenAMGN

——

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.16B+18.1%

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's total?: Agios Pharmaceuticals (AGIO) reported total of $932.21M in Q1 2026.
How has Agios Pharmaceuticals's total changed year-over-year?: Agios Pharmaceuticals's total decreased by 30.7% year-over-year, from $1.35B to $932.21M.
What is the long-term trend for Agios Pharmaceuticals's total?: Over 5 years (2020 to 2025), Agios Pharmaceuticals's total has grown at a 14.6% compound annual growth rate (CAGR), from $543M to $1.07B.